When using Citrasate dialysate, which statement is true regarding anticoagulation?

The statement regarding anticoagulation that is true when using Citrasate dialysate is that anticoagulation is improved, preventing clotting of fibers in the dialyzer. Citrasate is a citrate-based dialysate that functions by chelating calcium in the blood, which results in effective anticoagulation. This mechanism helps to maintain patency within the dialyzer by preventing the formation of clots, thereby ensuring a continuous and efficient dialysis process.

The ability of Citrasate to reduce the risk of clot formation is crucial in dialysis settings, where maintaining blood flow and clear access to the dialyzer is essential for treatment efficacy. With effective anticoagulation, patients can receive their dialysis treatment without complications related to clotting, enhancing both the safety and quality of care.

It is important to regularly monitor calcium levels during treatments involving citrate, as excessive use can lead to considerations of calcium administration to mitigate any potential hypocalcemia risks. However, the improved anticoagulation effect provided by Citrasate plays a critical role in preventing clotting in the dialysis fibers, which is the core aspect of this statement's validity.